• 2023
  Payet CA, You A, Fayet OM, Hemery E, Truffault F, Bondet V, Duffy D, Michel F, Fadel E, Guihaire J, Demeret S, Berrih-Aknin S, Le Panse R, , Central Role of Macrophages and Nucleic Acid Release in Myasthenia Gravis Thymus., Ann Neurol 2023 Apr; 93(4): 643-654.
• 2022
  Vuillier F, Li Z, Black I, Cruciani M, Rubino E, Michel F, Pellegrini S, , IFN-I inducible miR-3614-5p targets ADAR1 isoforms and fine tunes innate immune activation., Front Immunol 2022 ; 13(): 939907.
• 2021
  Devi-Marulkar P, Moraes-Cabe C, Campagne P, Corre B, Meghraoui-Kheddar A, Bondet V, Llibre A, Duffy D, Maillart E, Papeix C, Pellegrini S, Michel F, , Altered Immune Phenotypes and HLA-DQB1 Gene Variation in Multiple Sclerosis Patients Failing Interferon β Treatment., Front Immunol 2021 ; 12(): 628375.
• 2020
  Li Z, Rotival M, Patin E, Michel F, Pellegrini S, , Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosage., PLoS One 2020 ; 15(1): e0225289.
• 2020
  Rubino E, Cruciani M, Tchitchek N, Le Tortorec A, Rolland AD, Veli Ö, Vallet L, Gaggi G, Michel F, Dejucq-Rainsford N, Pellegrini S, , Human Ubiquitin-Specific Peptidase 18 Is Regulated by microRNAs via the 3’Untranslated Region, A Sequence Duplicated in Long Intergenic Non-coding RNA Genes Residing in chr22q11.21., Front Genet 2020 ; 11(): 627007.
• 2019
  Azébi S, Batsché E, Michel F, Kornobis E, Muchardt C, Expression of endogenous retroviruses reflects increased usage of atypical enhancers in T cells, EMBO J. 2019 May;.
• 2017
  Govender U, Corre B, Bourdache Y, Pellegrini S, Michel F, Type I interferon-enhanced IL-10 expression in human CD4 T cells is regulated by STAT3, STAT2, and BATF transcription factors, J. Leukoc. Biol. 2017 05;101(5):1181-1190.
• 2013
  Corre B, Perrier J, El Khouri M, Cerboni S, Pellegrini S, Michel F, Type I interferon potentiates T-cell receptor mediated induction of IL-10-producing CD4⁺ T cells, Eur. J. Immunol. 2013 Oct;43(10):2730-40.
• 2013
  Li Z, Gakovic M, Ragimbeau J, Eloranta ML, Rönnblom L, Michel F, Pellegrini S, , Two rare disease-associated Tyk2 variants are catalytically impaired but signaling competent., J Immunol 2013 Mar; 190(5): 2335-44.
• 2012
  Girard T, El-Far M, Gaucher D, Acuto O, Beaulé G, Michel F, Mourad W, Sékaly RP, , A conserved polylysine motif in CD86 cytoplasmic tail is necessary for cytoskeletal association and effective co-stimulation., Biochem Biophys Res Commun 2012 Jun; 423(2): 301-7.
• 2010
  Dong S, Corre B, Nika K, Pellegrini S, Michel F, T cell receptor signal initiation induced by low-grade stimulation requires the cooperation of LAT in human T cells, PLoS ONE 2010;5(11):e15114.
• 2008
  Acuto O, Di Bartolo V, Michel F, , Tailoring T-cell receptor signals by proximal negative feedback mechanisms., Nat Rev Immunol 2008 Sep; 8(9): 699-712.
• 2007
  Lizundia R, Chaussepied M, Naissant B, Masse GX, Quevillon E, Michel F, Monier S, Weitzman JB, Langsley G, , The JNK/AP-1 pathway upregulates expression of the recycling endosome rab11a gene in B cells transformed by Theileria., Cell Microbiol 2007 Aug; 9(8): 1936-45.
• 2007
  Di Bartolo V, Montagne B, Salek M, Jungwirth B, Carrette F, Fourtane J, Sol-Foulon N, Michel F, Schwartz O, Lehmann WD, Acuto O, , A novel pathway down-modulating T cell activation involves HPK-1-dependent recruitment of 14-3-3 proteins on SLP-76., J Exp Med 2007 Mar; 204(3): 681-91.
• 2006
  Dong S, Corre B, Foulon E, Dufour E, Veillette A, Acuto O, Michel F, T cell receptor for antigen induces linker for activation of T cell-dependent activation of a negative signaling complex involving Dok-2, SHIP-1, and Grb-2, J. Exp. Med. 2006 Oct;203(11):2509-18.
• 2006
  Martín-Cófreces NB, Sancho D, Fernández E, Vicente-Manzanares M, Gordón-Alonso M, Montoya MC, Michel F, Acuto O, Alarcón B, Sánchez-Madrid F, , Role of Fyn in the rearrangement of tubulin cytoskeleton induced through TCR., J Immunol 2006 Apr; 176(7): 4201-7.
• 2006
  Bernard D, Riteau B, Hansen JD, Phillips RB, Michel F, Boudinot P, Benmansour A, , Costimulatory receptors in a teleost fish: typical CD28, elusive CTLA4., J Immunol 2006 Apr; 176(7): 4191-200.
• 2005
  Rohrlich PS, Fazilleau N, Ginhoux F, Firat H, Michel F, Cochet M, Laham N, Roth MP, Pascolo S, Nato F, Coppin H, Charneau P, Danos O, Acuto O, Ehrlich R, Kanellopoulos J, Lemonnier FA, Direct recognition by alphabeta cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting function, Proc. Natl. Acad. Sci. U.S.A. 2005 Sep;102(36):12855-60.
• 2004
  Setterblad N, Blancheteau V, Delaguillaumie A, Michel F, Bécart S, Lombardi G, Acuto O, Charron D, Mooney N, , Cognate MHC-TCR interaction leads to apoptosis of antigen-presenting cells., J Leukoc Biol 2004 Jun; 75(6): 1036-44.
• 2003
  Acuto O, Michel F, CD28-mediated co-stimulation: a quantitative support for TCR signalling, Nat. Rev. Immunol. 2003 Dec;3(12):939-51.
• 2003
  Acuto O, Mise-Omata S, Mangino G, Michel F, , Molecular modifiers of T cell antigen receptor triggering threshold: the mechanism of CD28 costimulatory receptor., Immunol Rev 2003 Apr; 192(): 21-31.
• 2002
  Irles C, Symons A, Michel F, Bakker TR, van der Merwe PA, Acuto O, CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signaling, Nat. Immunol. 2003 Feb;4(2):189-97.
• 2002
  Guerra N, Michel F, Gati A, Gaudin C, Mishal Z, Escudier B, Acuto O, Chouaib S, Caignard A, , Engagement of the inhibitory receptor CD158a interrupts TCR signaling, preventing dynamic membrane reorganization in CTL/tumor cell interaction., Blood 2002 Oct; 100(8): 2874-81.
• 2002
  Michel F, Acuto O, , CD28 costimulation: a source of Vav-1 for TCR signaling with the help of SLP-76?, Sci STKE 2002 Aug; 2002(144): pe35.
• 2002
  Marinari B, Costanzo A, Viola A, Michel F, Mangino G, Acuto O, Levrero M, Piccolella E, Tuosto L, , Vav cooperates with CD28 to induce NF-kappaB activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1., Eur J Immunol 2002 Feb; 32(2): 447-56.
• 2001
  Michel F, Attal-Bonnefoy G, Mangino G, Mise-Omata S, Acuto O, , CD28 as a molecular amplifier extending TCR ligation and signaling capabilities., Immunity 2001 Dec; 15(6): 935-45.
• 2001
  Roumier A, Olivo-Marin JC, Arpin M, Michel F, Martin M, Mangeat P, Acuto O, Dautry-Varsat A, Alcover A, , The membrane-microfilament linker ezrin is involved in the formation of the immunological synapse and in T cell activation., Immunity 2001 Nov; 15(5): 715-28.
• 2001
  Ricci JE, Lang V, Luciano F, Belhacene N, Giordanengo V, Michel F, Bismuth G, Auberger P, , An absolute requirement for Fyn in T cell receptor-induced caspase activation and apoptosis., FASEB J 2001 Aug; 15(10): 1777-9.
• 2001
  Donnadieu E, Lang V, Bismuth G, Ellmeier W, Acuto O, Michel F, Trautmann A, , Differential roles of Lck and Itk in T cell response to antigen recognition revealed by calcium imaging and electron microscopy., J Immunol 2001 May; 166(9): 5540-9.
• 2000
  Michel F, Mangino G, Attal-Bonnefoy G, Tuosto L, Alcover A, Roumier A, Olive D, Acuto O, , CD28 utilizes Vav-1 to enhance TCR-proximal signaling and NF-AT activation., J Immunol 2000 Oct; 165(7): 3820-9.
• 2000
  Mascarell L, Frey JR, Michel F, Lefkovits I, Truffa-Bachi P, , Increased protein synthesis after T cell activation in presence of cyclosporin A., Transplantation 2000 Jul; 70(2): 340-8.
• 1999
  Lang V, Semichon M, Michel F, Brossard C, Gary-Gouy H, Bismuth G, , Fyn membrane localization is necessary to induce the constitutive tyrosine phosphorylation of Sam68 in the nucleus of T lymphocytes., J Immunol 1999 Jun; 162(12): 7224-32.
• 1999
  Di Bartolo V, Mège D, Germain V, Pelosi M, Dufour E, Michel F, Magistrelli G, Isacchi A, Acuto O, , Tyrosine 319, a newly identified phosphorylation site of ZAP-70, plays a critical role in T cell antigen receptor signaling., J Biol Chem 1999 Mar; 274(10): 6285-94.
• 1998
  Michel F, Grimaud L, Tuosto L, Acuto O, , Fyn and ZAP-70 are required for Vav phosphorylation in T cells stimulated by antigen-presenting cells., J Biol Chem 1998 Nov; 273(48): 31932-8.
• 1997
  Bousso P, Michel F, Pardigon N, Bercovici N, Liblau R, Kourilsky P, Abastado JP, , Enrichment of antigen-specific T lymphocytes by panning on immobilized MHC-peptide complexes., Immunol Lett 1997 Nov; 59(2): 85-91.
• 1997
  Thibodeau J, Dohlsten M, Cloutier I, Lavoie PM, Bjork P, Michel F, Léveillé C, Mourad W, Kalland T, Sékaly RP, , Molecular characterization and role in T cell activation of staphylococcal enterotoxin A binding to the HLA-DR alpha-chain., J Immunol 1997 Apr; 158(8): 3698-704.
• 1996
  Mège D, Di Bartolo V, Germain V, Tuosto L, Michel F, Acuto O, , Mutation of tyrosines 492/493 in the kinase domain of ZAP-70 affects multiple T-cell receptor signaling pathways., J Biol Chem 1996 Dec; 271(51): 32644-52.
• 1996
  Michel F, Acuto O, , Induction of T cell adhesion by antigen stimulation and modulation by the coreceptor CD4., Cell Immunol 1996 Nov; 173(2): 165-75.
• 1996
  Tuosto L, Michel F, Acuto O, , p95vav associates with tyrosine-phosphorylated SLP-76 in antigen-stimulated T cells., J Exp Med 1996 Sep; 184(3): 1161-6.
• 1993
  Michel F, Merle-Béral H, Legac E, Michel A, Debré P, Bismuth G, , Defective calcium response in B-chronic lymphocytic leukemia cells. Alteration of early protein tyrosine phosphorylation and of the mechanism responsible for cell calcium influx., J Immunol 1993 Apr; 150(8 Pt 1): 3624-33.
• 1992
  Michel F, Hoffenbach A, Froussard P, Langlade-Demoyen P, Kaczorek M, Kieny MP, Plata F, , HIV-1 env, nef, and gag-specific T-cell immunity in mice: conserved epitopes in nef p27 and gag p25 proteins., AIDS Res Hum Retroviruses 1992 Apr; 8(4): 469-78.
• 1992
  Dadaglio G, Michel F, Langlade-Demoyen P, Sansonetti P, Chevrier D, Vuillier F, Plata F, Hoffenbach A, , Enhancement of HIV-specific cytotoxic T lymphocyte responses by zidovudine (AZT) treatment., Clin Exp Immunol 1992 Jan; 87(1): 7-14.
• 1989
  Chenciner N, Michel F, Dadaglio G, Langlade-Demoyen P, Hoffenbach A, Leroux A, Garcia-Pons F, Rautmann G, Guy B, Guillon JM, , Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice., Eur J Immunol 1989 Sep; 19(9): 1537-44.
• 1989
  Hoffenbach A, Langlade-Demoyen P, Dadaglio G, Vilmer E, Michel F, Mayaud C, Autran B, Plata F, , Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans., J Immunol 1989 Jan; 142(2): 452-62.
• 1989
  Plata F, Dadaglio G, Chenciner N, Hoffenbach A, Wain-Hobson S, Michel F, Langlade-Demoyen P, , Cytotoxic T lymphocytes in HIV-induced disease: implications for therapy and vaccination., Immunodefic Rev 1989 ; 1(3): 227-46.
• 1988
  Michel F, Hoffenbach A, Langlade-Demoyen P, Guy B, Girard M, Lecocq JP, Wain-Hobson S, Kieny MP, Plata F, , HIV-specific T lymphocyte immunity in mice immunized with a recombinant vaccinia virus., Eur J Immunol 1988 Dec; 18(12): 1917-24.
• 1988
  Langlade-Demoyen P, Michel F, Hoffenbach A, Vilmer E, Dadaglio G, Garicia-Pons F, Mayaud C, Autran B, Wain-Hobson S, Plata F, , Immune recognition of AIDS virus antigens by human and murine cytotoxic T lymphocytes., J Immunol 1988 Sep; 141(6): 1949-57.
• 1987
  Rudent A, Michel F, Labarre C, Quero AM, Zalisz R, Smets P, , Enhancement of bronchoalveolar cell recovery and stimulation of alveolar macrophage chemiluminescence and resistance to influenza virus after treatment with RU 41821 aerosol., Antimicrob Agents Chemother 1987 Jun; 31(6): 920-4.
• 1987
  Michel F, Rudent A, Labarre C, Quero AM, Zalisz R, Smets P, , Effects of RU 41740 aerosol treatment on mouse bronchoalveolar cells, and protection afforded against influenza virus infection., Int J Immunopharmacol 1987 ; 9(7): 775-81.